When cancer returns as just a few small spots in the abdomen or pelvis, treatment options can be tricky. A small, early-phase study tested a highly targeted form of radiation called SMART on ten patients with this specific situation. The goal was to see if it was safe and feasible.
The results showed promise. After about four years, the radiation successfully controlled the treated spots in 90% of patients, and 90% of patients were still alive. Importantly, the treatment was well-tolerated, with only mild, short-term side effects reported. All ten patients completed the planned radiation course without complications.
However, this is a very early look. The study only included ten people, and it didn't compare SMART to any other treatment or to no treatment at all. While the treated spots were often controlled, cancer still spread to new, distant areas in many patients over time. This tells us the approach might manage local spots effectively, but it doesn't prevent the cancer from progressing elsewhere in the body. More research with more patients is needed to understand its full role.